Get started
Author

Ryuji Okuyama

Observed names: RYUJI OKUYAMA, 奥山 隆二, 奥山, 隆二, 隆二 奥山
OpenAlex ID: A5104110085
Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines
2004 · Fumito Ito, Qiao Li, et al. · Cancer Research · 109
PDF
Mechanisms Involved in Radiation Enhancement of Intratumoral Dendritic Cell Therapy
2008 · Seagal Teitz-Tennenbaum, Qiao Li, et al. · Journal of Immunotherapy · 84
Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer
2014 · Atsushi Aruga, Nobuhiro Takeshita, et al. · Journal of Translational Medicine · 82
PDF
Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2013 · Atsushi Aruga, Nobuhiro Takeshita, et al. · Clinical Cancer Research · 77
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
2013 · Ryuji Okuyama, Atsushi Aruga, et al. · OncoImmunology · 54
Phase I trial of Wilms' Tumor 1 (WT1) peptide vaccine with GM-CSF or CpG in patients with solid malignancy.
2012 · Satoshi Ohno, Ryuji Okuyama, et al. · PubMed · 43
Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
2013 · Ayako Nakamura, Go Nakajima, et al. · Gastric Cancer · 40
PDF
Effect of green tea extract on reactive oxygen species produced by neutrophils from cancer patients.
2012 · Katsuhiko Suzuki, Satoshi Ohno, et al. · PubMed · 20
Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab
2017 · Hidekazu Kuramochi, Masayuki Ando, et al. · Cancer Chemotherapy and Pharmacology · 14
Determination of chronic inflammatory states in cancer patients using assay of reactive oxygen species production by neutrophils.
2012 · Yoko Suzuki, Satoshi Ohno, et al. · PubMed · 10
Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer
2011 · AYAKO NAKAMURA, KAZUHIKO HAYASHI, et al. · Experimental and Therapeutic Medicine · 5
PDF
Enhanced Response of Growth Hormone to Growth Hormone‐Releasing Hormone and a Decreased Content of Hypothalamic Somatostatin in a Stress‐Induced Rat Model of Depression
1998 · Kenji Hamanaka, Hideaki Soya, et al. · Journal of Neuroendocrinology · 3
PDF
Supplementary Figure 2 from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
Supplementary Figure 1 from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
PDF
Supplementary Figure Legends from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
PDF
Supplementary Figure 1 from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
Supplementary Figure Legends from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
Supplementary Figure 2 from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
PDF
Data from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
Data from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2023 · Atsushi Aruga, Nobuhiro Takeshita, et al.
Abstract CT124: A phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, oxaliplatin, and bevacizumab
2016 · Go Nakajima, Hidekazu Kuramochi, et al. · Cancer Research
Ps-234-1 膵癌治癒切除症例に対するゲムシタビンとペプチドワクチンを併用した術後補助免疫化学療法の第i/ii相臨床試験(ps ポスターセッション,第113回日本外科学会定期学術集会)
2013 · 修司 鈴木, 隆 羽鳥, et al. · 日本外科学会雑誌
Abstract 5038: Non-cording microRNA hsa-miR-199a expression in hepatocellular carcinoma correlates with patient survival
2012 · Go Nakajima, Hidekazu Kuramochi, et al. · Cancer Research
P-0218 外来におけるXELOX±Bevacizumab(BV)療法およびmFOLFOX6±BV療法の実施状況に関する検討(一般演題 ポスター発表,がん薬物療法(外来化学療法),Enjoy Pharmacists' Lifestyles)
2011 · 利恵子 生駒, 恵美子 小林, et al. · 日本医療薬学会年会講演要旨集
Ps-127-7 治癒切除不能進行大腸癌患者に対するuft/lv併用癌ペプチドワクチン療法第i相臨床試験の最終解析(ps-127 ポスターセッション(127)大腸:集学的治療-1,第111回日本外科学会定期学術集会)
2011 · 典正 松下, 淳 有賀, et al. · 日本外科学会雑誌
Works count: 33
Citation count: 541
H-index: 10
I10-index: 10
Year
Topic
Type